Transesophageal Magnetic Resonance Imaging (MRI) in Conjunction With Lipid Lowering Measures
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
This research is being done to investigate the ability of an experimental imaging method -
transesophageal magnetic resonance imaging (TEMRI), to detect the change in aortic
atherosclerotic plaque burden and morphology between patients on high dose cholesterol
lowering medications and patients on standard dose cholesterol lowering medications. This
study will use TEMRI to see how atherosclerosis (cholesterol build up) changes with
cholesterol lowering medications. This study will also investigate whether these
cholesterol-lowering medications will change levels of blood tests, called inflammatory
markers, in patients' blood. People with atherosclerosis may join this study. This study will
also store blood samples for future studies of cardiac diseases; no gene testing will be
done.